baber/WOPTO huggingface dataset:
Patent AU-2021236444-A1 (AU)
Title: Laser marked optically variable device
Inventor: THURAILINGAM THIVAHARAN
IPC: B42D25/342
Filed: 2021-09-20
Abstract: A security device for security documents provides an angle-dependent Moire effect. A 
security device for a security document and method for making the security device are 
provided. At least two interlaced laser engraved images form an angle dependent 
parallax effect. First and second images are laser engraved at a substrate of the 
security document. To render the security device more difficult to copy, a colour 
changing effect or a nonreciprocal transmission effect may be achieved by adding a 
coloured (absorptive or emissive) layer between or within non-laser engravable layers 
situated between the laser engravable layers, and/or by adding a patterned phase 
diffraction grating situated between the laser engravable layers.
1/4 
Face 
100um LE 
100um LE 
205um NLE 
100um LE 
100um White 
150um LE 
Back 100um 
LE 
Transparent Region 
Figure 1 
Image al Image a2 
Figure 2 
Face 
NON-Laser engravable Layer 
Back L 
Transparent Region- Laser engraving 
Figure 3
Patent AU-2021240273-A1 (AU)
Title: Methods, apparatuses, and systems for processing game images
Inventor: XIE FEI
IPC: A63F1/00
Filed: 2021-09-24
Abstract: Methods, devices and systems for processing game images are provided by embodiments 
of the present disclosure. By detecting a game prop and a preset marker involved in a game 
image, a first detection result and a second detection result are acquired respectively for 
determining whether the game prop and the preset marker meet a preset first alert condition, 
and in a case that the first alert condition is satisfied, an alert message is generated 
automatically. In this way, wrong operations to the game prop and/or the preset marker within 
the game area can be detected automatically. As the above process does not involve any 
manual operations, it has relatively high detection efficiency and relatively low detection cost.
Patent AU-2021255809-A1 (AU)
Title: Bi- and monocyclic nucleoside analogs for treatment of hepatitis E
Inventor: JONCKERS TIM HUGO MARIA
IPC: A61K31/7072
Filed: 2021-04-13
Abstract: The present disclosure is directed toward bi- and monocyclic nucleoside analogs, and compositions comprising these compounds for use in the treatment of hepatitis E infections.
Patent AU-2021257946-A1 (AU)
Title: Information processing apparatus, information processing method, and non-transitory computer-readable storage medium
Inventor: TAKIMOTO MASAFUMI
IPC: G06Q50/02
Filed: 2021-10-26
Abstract: OF THE DISCLOSURE 
An information processing apparatus comprises a first selection unit 
configured to select, as at least one candidate learning model, at least one learning 
model from a plurality of learning models learned under learning environments 
different from each other based on information concerning image capturing of an 
object, a second selection unit configured to select at least one candidate learning 
model from the at least one candidate learning model based on a result of object 
detection processing by the at least one candidate learning model selected by the 
first selection unit, and a detection unit configured to perform the object detection 
processing for a captured image of the object using at least one candidate learning 
model of the at least one candidate learning model selected by the second 
selection unit.  
(Figure 1)
2/38 
F I G. 2A 
( START) 
S20 
CAPTURE FARM FIELD 
I r-1S22 
S21 ACQUIRE CAPTURED 
FARM FIELD PARAMETERS 
SET CAPTURED IMAGE 
AND EXIF INFORMATION AND 
TRANSMIT TO CLOUD SERVER 
AND INFORMATION 
PROCESSING APPARATUS 
SELECT LEARNING MODEL S23 
EXECUTE DETECTION 
BY SELECTED LEARNING MODEL -S24 
PERFORM ANALYSIS 
PROCESSING 
( END
Patent AU-2021272834-A1 (AU)
Title: Face mask
Inventor: MAGAR ADIL
IPC: A62B18/00
Filed: 2021-05-14
Abstract: A face mask (10c) comprises a shield (42) and a filter carrier (60). The shield (42) comprises a shaped body (50) which is shaped and dimensioned to fully cover the lower front portion of a user's face, that is the respiratory parts being the nostrils and mouth. The shield body (50) extends to a distance below the chin, which defines an opening space (53) from a lower periphery (51) of the shield body (50) to the user's chin or jaw. In the embodiment, the shield body (50) is made from waterproof, transparent, rigid or semi-rigid material. The opening space (53) is formed in use at a lower portion of the face mask (10c) below the chin and opens rearwardly towards the user's neck. The opening space (53) is fully covered by the filter carrier (60) with a filter (90) in use, which are thus both below the chin and do not cover the user's face in use. The filter carrier (60) and the filter (90) are covered from the front by the shield body (50). The transparent shield body (50) thus covers the bottom front portion of the user's face without any parts thereof blocking viewing the user's face. The filter carrier (60) is shaped to extend across the opening space (53) such that air moving in and out of the mask (10c) passes through the filter (90).
Patent AU-2021273662-A1 (AU)
Title: Industrial isolation of amino acids from plants using chromatography without organic solvent
Inventor: SHARMA DR REENA
IPC: A23J3/34
Filed: 2021-11-27
Abstract: INDUSTRIAL ISOLATION OF AMINO ACIDS FROM PLANTS USING 
CHROMATOGRAPHY WITHOUT ORGANIC SOLVENT 
The present invention provides methods of industrial isolation of amino acids from plants 
using chromatography without organic solvent.
Patent AU-2021277095-A1 (AU)
Title: Neural recording with stimulus crosstalk compensation
Inventor: SINGLE PETER SCOTT VALLACK
IPC: A61B5/271
Filed: 2021-05-18
Abstract: A device for recording evoked neural responses, comprising one or more stimulus electrodes and one or more sense electrodes. The device has a stimulus source for providing a stimulus to be delivered from the stimulus electrodes to a neural pathway in order to give rise to an evoked action potential on the neural pathway. The device has measurement circuitry for recording a neural compound action potential signal sensed at the sense electrodes. Crosstalk cancellation circuitry is configured to produce a stimulus crosstalk cancellation signal, and is configured to inject the stimulus crosstalk cancellation signal into the measurement circuitry. The stimulus crosstalk cancellation signal is configured to cancel a stimulus crosstalk voltage arising upon the one or more sense electrodes as a result of delivery of the stimulus.
Patent AU-2021290224-A1 (AU)
Title: Cancer treatment based on delivery of oligoes via Gap Junctions from Human Mesenchymal Stem Cells (hMSC)
Inventor: COHEN IRA S
IPC: C07H21/00
Filed: 2021-12-20
Abstract: A method of treating cancer in vivo includes introducing in vitro into human mesenchymal stem cells 
(hMSCs) at least one type of inhibitory oligonucleotide, and contacting a tumor tissue of syncytial cancer 
cells with the hMSCs in vivo under conditions permitting a hMSC to form a gap junction channel with a first 
syncytial cancer cell of the tumor tissue. As a result, the at least one type of inhibitory oligonucleotide is 
delivered into the first syncytial cancer cell by traversing the gap junction channel and the at least one type of 
inhibitory oligonucleotide is delivered into a second syncytial cancer cell of the tumor tissue by traversing a 
gap junction channel between the first syncytial cancer cell and the second syncytial cancer cell.
Patent AU-2021300013-A1 (AU)
Title: Tree shelter
Inventor: HURLSTONE GARY
IPC: A01G13/02
Filed: 2021-06-25
Abstract: A tree shelter comprising an elongate tubular body having a wall formed from a biodegradable material comprising a natural fibre substrate and a matrix of a natural binder in which the fibres are held.
Patent AU-2021300831-A1 (AU)
Title: RIP1k inhibitors
Inventor: BHAMIDIPATI SOMASEKHAR
IPC: A61K31/55
Filed: 2021-06-25
Abstract: Disclosed herein are kinase inhibitory compounds, such as a receptor-interacting protein-1 (RIP1) kinase inhibitor compounds, as well as pharmaceutical compositions and combinations comprising such inhibitory compounds. The disclosed compounds, pharmaceutical compositions, and/or combinations may be used to treat or prevent a kinase-associated disease or condition, particularly a RIP1-associated disease or condition. (I)
Patent AU-2021315898-A1 (AU)
Title: Novel gastroretentive extended release dosage form
Inventor: ZHOU FANG
IPC: A61K9/00
Filed: 2021-07-28
Abstract: A novel orally administrable dosage form including a drug/active layer for loading a therapeutic agent and an extenstion layer for retaining the API or drug dosage form in the stomach of a subject in need thereof. Also disclosed is a method of treating diseases with the dosage form.
Patent AU-2021329915-A1 (AU)
Title: Organic heat transfer system, method and fluid
Inventor: AGIRAL ANIL
IPC: C09K5/10
Filed: 2021-08-19
Abstract: The disclosed technology relates to a heat transfer system and heat transfer method employing stable colloidal dispersion of a) a non-conductive, non-aqueous and non-water miscible dielectric oleaginous heat transfer fluid, b) at least one solid nanoparticle, and c) a surfactant. In particular, the technology relates to a stable colloidal dispersion with low electrical conductivity, low flammability, and low freeze point that provides excellent peak temperature reduction in a heat transfer system, such as that for cooling a battery pack or a power system of an electric vehicle.
Patent AU-2021345497-A1 (AU)
Title: Electric vehicle charging systems and methods
Inventor: CROSSMAN CHRIS
IPC: B60L53/65
Filed: 2021-09-16
Abstract: An electrical vehicle charging system and method is provided. The electric vehicle charging system comprises: a plurality of electric vehicle charging stations; a plurality of electric vehicles, each of the electric vehicles including a vehicle module which includes a positioning module, configured to determine a position of the vehicle, and an identifier associated with the vehicle; and one or more remote servers, coupled to the plurality of electric vehicle charging stations, and the vehicle module. The one or more remote servers are configured to: receive positioning data and the identifier from the vehicle; associate the vehicle with a charging station of the plurality of electric vehicle charging stations according to the positioning data; and cause the associated charging station to charge the electric vehicle upon authentication of the vehicle using the identifier or a derivative thereof.
Patent AU-2021351632-A1 (AU)
Title: System and method for a multi-primary wide gamut color system
Inventor: MANDLE GARY B
IPC: G09G3/20
Filed: 2021-08-31
Abstract: Systems and methods for a multi-primary color system for display. A multi-primary color system increases the number of primary colors available in a color system and color system equipment. Increasing the number of primary colors reduces metameric errors from viewer to viewer. One embodiment of the multi-primary color system includes Red, Green, Blue, Cyan, Yellow, and Magenta primaries. The systems of the present invention maintain compatibility with existing color systems and equipment and provide systems for backwards compatibility with older color systems.
Patent AU-2021378152-A1 (AU)
Title: COMBINATION OF AN ANTIBODY-DRUG CONJUGATE WITH ANTI-SIRPα ANTIBODY
Inventor: SUE MAYUMI
IPC: A61P43/00
Filed: 2021-11-10
Abstract: Provided are a pharmaceutical composition and a treatment method that are excellent in terms of antitumor effect and safety. A pharmaceutical composition and a treatment method characterized in that an antibody-drug conjugate, in which a drug linker shown by the formula (in the formula, A represents the binding site with the antibody) and an antibody are bonded by a thioether bond, is administered in combination with an SIRPα-CD47 interaction inhibitor such as an anti-SIRPα antibody, etc. Also, a pharmaceutical composition and a treatment method characterized in that the antibody-drug conjugate and an SIRPα-CD47 interaction inhibitor such as an anti-SIRPα antibody, etc., are administered in combination and used to treat a disease which is improved by the action of activating antitumor immunity.
Patent AU-2021457849-A1 (AU)
Title: Systems and methods for collapsing and loading a prosthetic device
Inventor: GIORDANO GIOVANNI
IPC: A61F2/95
Filed: 2021-07-29
Abstract: Systems and methods are provided for collapsing and loading a prosthetic device for delivery to a patient. The collapsing and loading systems described herein may facilitate more efficient and consistent positioning of a prosthetic device with respect to a collapser system and a corresponding delivery system. For example, the system may include a collapser system having a base and a collapser movably coupled to the base. The collapser defines an orifice sized and shaped to receive a prosthetic device (e.g., a prosthetic heart valve) in a first position and may be moved relative to the base to a second position for loading and collapsing the prosthetic device onto a delivery system.
Patent WO-2022251902-A1 (WO)
Inventor: SARLIN SHANE
IPC: G09B9/00
Filed: 2022-05-30
Abstract: Selon l'invention, le système utilise la réalité virtuelle comme outil pour accélérer l'intégration de système de systèmes de soldat en analysant les effets sur le système de soldat lorsqu'un nouvel élément est introduit. Le système fonctionne par l'intermédiaire d'un casque de réalité virtuelle (dispositif client) connecté par l'intermédiaire d'une interface basée sur le Web et est mis à jour à distance en fonction de besoins d'utilisateur et d'entrées de modèle virtuel d'utilisateur. Le système représente précisément un soldat moderne dans une configuration contemporaine avec un équipement complet et l'utilisateur peut localiser et appliquer virtuellement son modèle virtuel sur le soldat configuré pour le système pour mesurer et analyser l'impact de cet ajout sur le système de systèmes de soldat. La plateforme permet une expérimentation de configuration pour éclairer une sélection d'équipement physique, notamment un ou plusieurs paramètres parmi la configuration, le poids, la mobilité, l'amplitude des mouvements, la charge thermique et la protection personnelle relatifs par rapport à la configuration d'origine du système de soldat.
Patent WO-2023115136-A1 (WO)
Inventor: WILLIAMS MATTHEW MARLON
IPC: A61N1/36
Filed: 2022-12-22
Abstract: Est divulgué un système de programmation assistée pour un dispositif de neuromodulation qui est conçu pour aider un médecin à programmer efficacement le dispositif de neuromodulation pour un patient donné. En particulier, le système de programmation assistée comprend un processeur conçu pour prédire des seuils physiologiques d'une configuration donnée d'électrodes de stimulation à partir de marqueurs perceptifs obtenus à l'aide de réponses rapportées par le patient à des stimuli neuronaux délivrés par l'intermédiaire de cette configuration d'électrodes de stimulation. En variante, le processeur peut être conçu pour prédire des marqueurs perceptifs d'une configuration donnée d'électrodes de stimulation à partir de seuils physiologiques obtenus à l'aide de réponses neuronales mesurées à des stimuli neuronaux délivrés par l'intermédiaire de cette configuration d'électrodes de stimulation.
Patent AU-2022200958-A1 (AU)
Title: System and method for preparing a patient's femur in an orthopaedic joint replacement procedure
Inventor: LASHURE DANIEL E
IPC: A61F2/46
Filed: 2022-02-14
Abstract: OF THE DISCLOSURE 
An orthopaedic joint replacement system is shown and described.  
The system includes a number of prosthetic components configured to be 
implanted into a patient's knee. The system also includes a number of 
surgical instruments configured for use in preparing the bones of the patient's 
knee to receive the implants. A method or technique for using the surgical 
instruments to prepare the bones is also disclosed.  
DMS 4916790v1
Patent AU-2022203554-A1 (AU)
Title: Combination therapy for the treatment of cancer
Inventor: STRUM JAY C
IPC: C07D487/14
Filed: 2022-05-25
Abstract: Compositions, combinations and methods comprising the administration of a CDK4/6 
inhibitor of Formula D with a selective estrogen receptor downregulator of Formula A, B or 
C that are advantageous for the treatment of abnormal cellular proliferation, including a 
cancer or a tumor.
Patent AU-2022215300-A1 (AU)
Title: Automatic identification method, apparatus and device for detection results of immunoreagent card
Inventor: FANG JIANQIU
IPC: G01N33/558
Filed: 2022-08-12
Abstract: The present invention provides an automatic identification method, apparatus and 
device for detection results of an immunoreagent card. The method includes: identifying a 
detection character and an identification code on a detection image of an obtained 
immunoreagent card; forming a corresponding target area based on the detection character, 
determining a central sub-area in the target area and calculating histogram information of the 
central sub-area; detecting a non-uniform area in the target area when the histogram 
information of the central sub-area is between a minimum grayscale statistical threshold and 
a maximum grayscale statistical threshold, and conducting brightness equalization 
processing on the non-uniform area; calculating the histogram information of the target area 
after equalization processing and determining a chromaticity of the target area based on a 
grayscale statistical threshold; forming an immune result of automatic identification of the 
immunoreagent card according to the chromaticity of the target area corresponding to each 
detection character; and binding the identified immune result with a serial number 
corresponding to the identification code of the immunoreagent card, and returning the 
identified immune result to a user.
4/6 
FIG.5
Patent AU-2022228541-A1 (AU)
Title: Long-acting amylin receptor agonists and uses thereof
Inventor: ABRAHAM MILATA MARY
IPC: C07K14/605
Filed: 2022-03-02
Abstract: The present disclosure relates to the field of medicine. More particularly, the disclosure is in the field of treatment of diabetes, obesity and/or chronic weight management, dyslipidemia and/or NASH. The disclosure relates to compounds that agonize the amylin receptor and can lower food intake, body weight, glucose and/or triglycerides, so can be used to treat diabetes, obesity, and/or dyslipidemia. The present disclosure also includes pharmaceutical compositions containing such compounds and therapeutic uses of such compounds and compositions.
Patent AU-2022237561-A1 (AU)
Title: Methods of treating cancer with pdgfr alpha inhibitors
Inventor: OAKLEY GERARD JOSEPH III
IPC: C07K16/00
Filed: 2022-03-17
Abstract: Methods for treating cancer patients with human platelet derived growth factor receptor alpha inhibiting compounds, in which the patient is identified as having a cancer that is human platelet derived growth factor receptor beta negative.
Patent AU-2022238281-A1 (AU)
Title: Bulk bag conditioner
Inventor: EUCULANO JASON STEVEN
IPC: B65G69/08
Filed: 2022-02-22
Abstract: A bulk bag conditioner assembly is disclosed herein. The assembly includes a frame assembly defining a bulk bag conditioning area. The frame assembly includes a first carrier frame with a first ram, and a second carrier frame with a second ram. A first actuator assembly includes a first end fixed to the first carrier frame and a second end fixed to the second carrier frame. A second actuator assembly includes a first end fixed to the first carrier frame and a second end fixed to the second carrier frame. A control unit is configured to simultaneously drive the first ram and the second ram linearly towards each other to engage a bulk bag within the bulk bag conditioning area.
Patent AU-2022246476-A1 (AU)
Title: Protective member, track assembly and working machine
Inventor: LU JIALIN
IPC: B62D55/08
Filed: 2022-01-29
Abstract: The present application provides a protective member, a track assembly and a working 
machine. The protective member includes a substrate portion and a protrusion portion; the 
protrusion portion is provided on a side of the substrate portion, and a side of the protrusion 
portion away from the substrate portion is provided with a counterbore. The counterbore is used 
to accommodate an external fastener. In the track assembly, by arranging the above-mentioned 
matching structure between the protective member and the fastener, the collision and/or 
extrusion of the fastener can be effectively avoided, and the protection of the fastener can be 
realized. Therefore, the structure is simple, and the use effect is good. In the working machine, 
by arranging the above-mentioned track assembly, compared with the traditional working 
machine, the fastener can be protected without using a thick track shoe, and the weight can be 
reduced while the durability is improved.  
100 
C D E 
121 
BV B 
122 
O 121 
120 130 110 12 0 \- E 
C D 
FIG.4
Patent AU-2022255538-A1 (AU)
Title: Genetically modified oncolytic herpes simplex virus delivering chemokine and tumor associated/specific antigen
Inventor: CHEN XIAOQING
IPC: A61K35/76
Filed: 2022-04-07
Abstract: Disclosed is a genetically modified oncolytic herpes simplex virus (oHSV) encoding a truncated nonsignaling variant of at least one tumor associated/specific antigen, and at least one chemokine. The expression of the truncated nonsignaling variant and the chemokine is under the control of an immediate-early gene promoter of HSV, and the truncated nonsignaling variant is expressed and presented on a tumor cell surface as a biomarker upon replication of the oHSV in the tumor cell, and the chemokine is expressed and released to induce chemotaxis of an immune cell towards the tumor cell. The genetically modified oHSV can be used in combination with CAR-T, ADC, and/or BiTE therapies.
Patent AU-2022256501-A1 (AU)
Title: Authenticated messaging session with contactless card authentication
Inventor: GUO ROCKY
IPC: G06F21/35
Filed: 2022-04-15
Abstract: The exemplary embodiments described herein overcome problems encountered by conventional systems by providing an authenticated messaging environment in which a user can securely message with a programmatic intelligent agent. The user may be authenticated at the prompting of the programmatic intelligent agent, such as the beginning of a messaging session or when the user submits a request that requires access to sensitive or confidential information or requires access to a secure account. The prompt may take the form of a message sent from the programmatic intelligent agent. The message may contain a link for launching code, such as an application, that facilitates authentication of the user's identity. The user may activate the link to launch the code and then perform the steps requested by the code to perform the authentication.
Patent AU-2022267402-A1 (AU)
Title: A reconfigurable bit assembly
Inventor: SMITH CAMERON
IPC: B25B15/00
Filed: 2022-04-29
Abstract: A bit assembly comprises a screwdriver bit having a non-circular shank having a proximal end and a distal screwdriver tip and a sleeve having a bore therethrough. The sleeve may be put in a stowed position so that the screwdriver bit may be used to turn a first type of fastener suited for the screwdriver bit or the sleeve may be put in the in-use position so that the socket may be used to turn a second type of fastener suited for the socket.
Patent AU-2022289731-A1 (AU)
Title: Thrombus removal systems and associated methods
Inventor: AL-JADDA AADEL
IPC: A61B17/3207
Filed: 2022-06-10
Abstract: The present technology relates to systems and methods for removing a thrombus from a blood vessel of a patient. In some embodiments, the present technology is directed to systems including an elongated catheter having a distal portion configured to be positioned within the blood vessel of the patient, a proximal portion configured to be external to the patient, and a lumen extending therebetween. The system can also include a fluid delivery mechanism coupled with a fluid lumen and configured to apply fluid to at least partially fragment the thrombus.